Literature DB >> 1916751

Hepatic amyloidosis: morphologic differences between systemic AL and AA types.

F S Buck1, M N Koss.   

Abstract

The liver is almost universally involved in systemic amyloidosis. Patterns of topographic distribution of amyloid within the liver lobule have been recognized, but the reliability of using these for classification of amyloid type is in question. We examined 286 livers from cases of systemic amyloidosis obtained from autopsies at Los Angeles County-University of Southern California Medical Center, classifying them as AL or AA type by means of the potassium permanganate Congo red-staining method along with a specific anti-AA antiserum. Prior publications have asserted that deposition of secondary (AA) amyloidosis is limited to the vessels in the portal tract, constituting a "vascular" pattern, and that in primary (AL) amyloidosis the deposits exhibit a "sinusoidal" pattern in that they are seen along hepatic sinusoids as well as in portal vessels. We confirmed that AL amyloid involves the portal vessels as frequently as AA amyloid and that deposition occurred significantly more frequently in the portal stroma, the central vein, and the "sinusoidal" areas. However, we also found a "sinusoidal" pattern in 29 of 78 cases of secondary (AA) amyloidosis; in 14 of these, more than half of the sinusoidal spaces were replaced by amyloid deposits. We also noted that in 23 of the 29 AA amyloidosis cases with "sinusoidal" involvement, a "sago" pattern of distribution of amyloid in the spleen was present. No consistent association of a specific chronic inflammatory disease with "sago" spleen and "sinusoidal" deposits could be documented. We conclude that topographic distribution of amyloid within the liver lobule is not a reliable method of distinguishing AA from AL amyloidosis and that specific staining methods must be used if the physician is to be able to attempt modern therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916751     DOI: 10.1016/0046-8177(91)90180-w

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis.

Authors:  O Hashimoto; M Harada; M Sata; K Imamura; N Matsukuma; H Fukushima; S Itano; M Ohishi; T Ueno; A Iemura
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

2.  Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease.

Authors:  Saulius Girnius; David C Seldin; Martha Skinner; Kathleen T Finn; Karen Quillen; Gheorghe Doros; Vaishali Sanchorawala
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

3.  [Amyloidosis in liver biopsies].

Authors:  Z Gioeva; B Kieninger; C Röcken
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

4.  Along for the Ride: Intrahepatic Cholangiocarcinoma with Concomitant LECT2 Amyloidosis.

Authors:  Phoenix D Bell; Aaron R Huber; Tom C DeRoche
Journal:  Case Rep Pathol       Date:  2020-07-16

5.  Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.

Authors:  Yong-Mei Guo; Nagi Takahashi; Ken Miyabe; Makoto Yoshida; Fumito Abe; Takaya Yamashita; Miho Nara; Tomoko Yoshioka; Kenichi Ohashi; Akiteru Goto; Naoto Takahashi
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

6.  Hepatic manifestations in hematological disorders.

Authors:  Jun Murakami; Yukihiro Shimizu
Journal:  Int J Hepatol       Date:  2013-03-31

7.  Systemic Reactive Amyloidosis Associated with Castleman's Disease.

Authors:  Vinaya Gaduputi; Hassan Tariq; Kanthi Badipatla; Ariyo Ihimoyan
Journal:  Case Rep Gastroenterol       Date:  2013-11-12

8.  18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.

Authors:  Akinobu Tawada; Tatsuo Kanda; Takashi Oide; Toshio Tsuyuguchi; Fumio Imazeki; Yukio Nakatani; Osamu Yokosuka
Journal:  Int Med Case Rep J       Date:  2014-06-20

Review 9.  Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting.

Authors:  Robert Kisilevsky; Sara Raimondi; Vittorio Bellotti
Journal:  Front Mol Biosci       Date:  2016-05-09

10.  Amyloidosis: an unusual cause of portal hypertension.

Authors:  Vilma Takayasu; Lorena Silva Laborda; Raquel Bernardelli; Henrique Trombini Pinesi; Marilia Polo Minguete E Silva; Viviane Chiavelli; Angélica Braz Simões; Aloisio Felipe-Silva
Journal:  Autops Case Rep       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.